Regio- and diastereoselective construction of 1′,2′-(dihydrospiro[indoline-3,3′-pyrrol]-2′-yl)acrylates through phosphine-catalyzed [4 + 1] annulation of Morita–Baylis–Hillman carbonates with oxindole-derived α,β-unsaturated imines

Yu Leia, Xiao-Nan Zhanga, Xue-Yan Yanga, Qin Xu*a and Min Shi*ab
aKey Laboratory for Advanced Materials and Institute of Fine Chemicals, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, P. R. China. E-mail: mshi@mail.sioc.ac.cn
bState Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 354 Fenglin Road, Shanghai 200032, P. R. China

Received 17th April 2015 , Accepted 20th May 2015

First published on 26th May 2015


Abstract

Phosphine-catalyzed [4 + 1] annulation of Morita–Baylis–Hillman (MBH) carbonates with oxindole-derived α,β-unsaturated imines has been developed, giving the corresponding 1′,2′-(dihydrospiro[indoline-3,3′-pyrrol]-2′-yl)acrylates in moderate to good yields and diastereoselectivities under mild conditions.


Spirooxindole backbones have drawn tremendous interest in the area of synthetic organic chemistry and medicinal chemistry since they are the core structures in a variety of pharmacological agents and natural alkaloids1 and have various types of biological activities.2 For example, the 1′,2′-dihydrospiro[indoline-3,3′-pyrrol]-2-one featuring the molecular structures of spirotryprostatin B is a mammalian cell cycle inhibitor.1d Moreover, the spiro[indoline-3,3′-pyrrolidin]-2-one skeleton as a structural characteristic has been found in alkaloid rhynchophylline (Fig. 1).1b Therefore, they have recently become one of the most attractive synthetic targets for organic chemists. Subsequently, many kinds of elegant synthetic approaches have been thus far developed for their syntheses.3
image file: c5ra09147k-f1.tif
Fig. 1 Selected examples of natural products with spirooxindole motifs.

Over the past decade, nucleophilic phosphine catalysis has made significant progress4 and phosphine-mediated/catalyzed annulations have emerged as a powerful tool for the synthesis of a variety of unique carbo- and heterocyclic frameworks.5 In this arena, Lu and coworkers first reported a series of intra- and intermolecular [3 + n] annulations (n = 2, 4, 6) using Morita–Baylis–Hillman (MBH) carbonates as 1,3-dipoles with various electron-deficient olefins catalyzed by tertiary phosphine, affording the corresponding cycloadducts in good yield and high regioselectivities under mild conditions.6 Furthermore, [3 + 2] annulations of allenoates/alkynes or MBH acetate/carbonates with electron-deficient alkenes or imines have been widely explored and established as an effective method for constructing a wide range of highly functionalized five-membered ring systems.7 Apart from phosphine-catalyzed [3 + 2] annulations, phosphine-catalyzed [4 + 1] annulations are also efficient methodologies to construct functionalized five-membered carbo- and heterocycles. Recently, Zhang,8 Huang,9 He,10 Shi,11 Lu12 and Fu13 as well as their co-workers have developed many [4 + 1] annulations utilizing MBH carbonates, maleimides14 or others as 1,1-dipoles with various electron-deficient alkenes to obtain the desired heterocyclic products in high yields under mild conditions, respectively also along with their asymmetric versions. Another type of [4 + 1] annulation was disclosed by Tong15 in 2010, using 2,3-butadienoate as a C4 synthon under phosphine catalysis to construct cyclopentene containing products.

α,β-unsaturated imines as synthetically useful C2 or C4 synthons have been widely utilized to construct multifunctional five- and six-membered heterocycles.10a,16,17 Our group has reported an efficient method to construct spiro-fused six-membered heterocycles through [4 + 2] annulations of vinyl ketones with oxindole-derived α,β-unsaturated imines in the presence of phosphine.17c However, to the best of our knowledge, there has been no report on phosphine-catalyzed synthesis of isatin-based spiro-fused five-membered heterocycles through [4 + 1] annulation by oxindole-derived α,β-unsaturated imines.17 Herein, we wish to disclose a phosphine-catalyzed regio- and diastereoselective [4 + 1] annulation of MBH carbonates with oxindole-derived α,β-unsaturated imines to produce 1′,2′-(dihydrospiro[indoline-3,3′-pyrrol]-2′-yl)acrylates in moderate to good yields and moderate to good diastereoselectivities under mild conditions (Scheme 1).


image file: c5ra09147k-s1.tif
Scheme 1 Phosphine-catalyzed annulations of oxindole-derived α,β-unsaturated imines to construct six- or five-membered spiro heterocyclic compounds.

Initially, we examined the reaction outcome of oxindole-derived α,β-unsaturated imine 1a (0.1 mmol) with MBH carbonate 2a (0.12 mmol, 1.2 equiv.) catalyzed by PPh3 in toluene (1.0 mL) at room temperature. The desired [4 + 1] cycloadduct 3a was obtained in 90% total yield along with 1.2[thin space (1/6-em)]:[thin space (1/6-em)]1 dr value within 24 h (Table 1, entry 1). To improve the dr value, other phosphines such as P(p-MeOC6H4)3, P(p-FC6H4)3, PPh2Me, PPhMe2, PBu3, and dppb were further tested in this reaction and the results of these experiments are summarized in Table 1. It was found that PPh2Me is the best catalyst, affording 3a in 90% total yield along with 5.5[thin space (1/6-em)]:[thin space (1/6-em)]1 dr value (Table 1, entries 1–7). We next examined the solvent effects of this reaction in CH2Cl2, THF, MeCN or Et2O. It was found that toluene is the best solvent in this reaction (Table 1, entries 8–11). Reducing the reaction temperature to 0 °C gave the corresponding annulation product 3a in 88% total yield along with 8[thin space (1/6-em)]:[thin space (1/6-em)]1 dr (Table 1, entry 12). Therefore, the best reaction conditions have been determined as that using PPh2Me (20 mol%) as the catalyst and carrying out the reaction in toluene at 0 °C within 24 hours.

Table 1 Optimization of reaction conditions for the [4 + 1] annulation

image file: c5ra09147k-u1.tif

Entry Catalyst Solvent Time (h) Yielda (%) drb (%)
a Yield was determined by 1H NMR spectroscopic data of crude products using 1,3,5-trimethoxybenzene as a calibrated internal standard.b Determined 1H NMR spectroscopic data of crude products.c The reaction mixtures were stirred at 0 °C.
1 PPh3 Toluene 24 90 1.2[thin space (1/6-em)]:[thin space (1/6-em)]1
2 P(p-MeOC6H4)3 Toluene 24 78 4[thin space (1/6-em)]:[thin space (1/6-em)]1
3 P(p-FC6H4)3 Toluene 48 82 1.6[thin space (1/6-em)]:[thin space (1/6-em)]1
4 PPh2Me Toluene 24 90 5.5[thin space (1/6-em)]:[thin space (1/6-em)]1
5 PPhMe2 Toluene 12 89 1.2[thin space (1/6-em)]:[thin space (1/6-em)]1
6 PBu3 Toluene 12 55 1.1[thin space (1/6-em)]:[thin space (1/6-em)]1
7 dppb Toluene 24 60 4[thin space (1/6-em)]:[thin space (1/6-em)]1
8 PPh2Me CH2Cl2 24 69 2[thin space (1/6-em)]:[thin space (1/6-em)]1
9 PPh2Me THF 24 66 3[thin space (1/6-em)]:[thin space (1/6-em)]1
10 PPh2Me MeCN 24 65 3[thin space (1/6-em)]:[thin space (1/6-em)]1
11 PPh2Me Et2O 24 81 3[thin space (1/6-em)]:[thin space (1/6-em)]1
12c PPh2Me Toluene 24 88 8[thin space (1/6-em)]:[thin space (1/6-em)]1


With the optimized reaction conditions in hand, we next turned our attention to the scope and limitations of this reaction using a variety of oxindole-derived α,β-unsaturated imines 1 with MBH carbonates 2 and the results are summarized in Table 2. Using MBH carbonate 2a as substrate, we examined its reaction with various substituted oxindole-derived α,β-unsaturated imines 1b–1t and found that these [4 + 1] annulation proceeded smoothly to give the desired products in moderate to good yields. Substrates with electron-rich or electron-withdrawing substituents on the Ar group gave the corresponding products 3b–3g in good yields (up to 95% yield) and good dr values (up to 9[thin space (1/6-em)]:[thin space (1/6-em)]1 dr), respectively (Table 2, entries 1–6). We next examined oxindole-derived α,β-unsaturated imines 1h–1o bearing different substituents on their benzene rings of oxindole or having different N-protecting groups, and it was found that all of the reactions proceeded very well to produce the corresponding products 3h–3o in moderate to good yields along with good dr values (Table 2, entries 7–14). It should be pointed out that when electron-withdrawing substituents were introduced on their benzene rings, the reactions afforded the desired products in slightly lower yields, but with better diastereoselectivities perhaps due to the electronic effect (Table 2, entries 9–14). When R2 was a heteroaromatic group (R2 = 2-thienyl), the reactions also proceeded efficiently to produce the corresponding products 3p–3r in good yields and good dr values, respectively (Table 2, entries 15–17). When R2 was a sterically more bulky 2,4,6-triisopropylphenyl moiety, the desired spirooxindole products 3s and 3t could also be obtained in good yields, but in lower diastereoselectivities (Table 2, entries 18 and 19). The relative configuration of the major diastereoisomer of 3t was assigned by X-ray diffraction (see the ESI).18 Ethyl 2-(((tert-butoxycarbonyl)oxy)methyl)acrylate 2b was also used to react with 1a, affording the corresponding product 3u in 85% yield and moderate dr value (dr = 5[thin space (1/6-em)]:[thin space (1/6-em)]1) (Table 2, entry 20) and the configuration of the major diastereoisomer of 3u was also assigned by X-ray diffraction. Its ORTEP drawing is shown in Fig. 2 and the corresponding CIF data are presented in the ESI.18

Table 2 Substrate scope of the [4 + 1] annulation of 1 with 2

image file: c5ra09147k-u2.tif

Entrya Ar R1 R2 R3 R4 Yieldb (%) drc
a 1 (0.2 mmol), 2 (0.3 mmol) and PPh2Me (0.04 mmol) were stirred in 1.0 mL of toluene at 0 °C within 24 h.b Isolated yield.c Determined by 1H NMR spectroscopic data of crude products.
1 4-FC6H4 H 4-Methylphenyl Me tBu 3b, 72 8[thin space (1/6-em)]:[thin space (1/6-em)]1
2 4-ClC6H4 H 4-Methylphenyl Me tBu 3c, 84 8[thin space (1/6-em)]:[thin space (1/6-em)]1
3 4-BrC6H4 H 4-Methylphenyl Me tBu 3d, 78 7[thin space (1/6-em)]:[thin space (1/6-em)]1
4 4-MeOC6H4 H 4-Methylphenyl Me tBu 3e, 95 9[thin space (1/6-em)]:[thin space (1/6-em)]1
5 4-MeC6H4 H 4-Methylphenyl Me tBu 3f, 86 7[thin space (1/6-em)]:[thin space (1/6-em)]1
6 4-(CH3)3CC6H4 H 4-Methylphenyl Me tBu 3g, 88 7[thin space (1/6-em)]:[thin space (1/6-em)]1
7 4-MeOC6H4 5-Me 4-Methylphenyl Me tBu 3h, 88 9[thin space (1/6-em)]:[thin space (1/6-em)]1
8 4-MeOC6H4 6-MeO 4-Methylphenyl Me tBu 3i, 84 5[thin space (1/6-em)]:[thin space (1/6-em)]1
9 4-MeOC6H4 5 F 4-Methylphenyl Me tBu 3j, 63 20[thin space (1/6-em)]:[thin space (1/6-em)]1
10 4-MeOC6H4 5-Cl 4-Methylphenyl Me tBu 3k, 65 20[thin space (1/6-em)]:[thin space (1/6-em)]1
11 4-MeOC6H4 6-Cl 4-Methylphenyl Me tBu 3l, 54 20[thin space (1/6-em)]:[thin space (1/6-em)]1
12 4-MeOC6H4 5-Br 4-Methylphenyl Me tBu 3m, 68 20[thin space (1/6-em)]:[thin space (1/6-em)]1
13 C6H5 5-Cl 4-Methylphenyl Bn tBu 3n, 62 12[thin space (1/6-em)]:[thin space (1/6-em)]1
14 C6H5 5-Cl 4-Methylphenyl Allyl tBu 3o, 68 10[thin space (1/6-em)]:[thin space (1/6-em)]1
15 C6H5 H 2-Thienyl Me tBu 3p, 84 9[thin space (1/6-em)]:[thin space (1/6-em)]1
16 4-MeOC6H4 H 2-Thienyl Me tBu 3q, 80 8[thin space (1/6-em)]:[thin space (1/6-em)]1
17 4-MeC6H4 H 2-Thienyl Me tBu 3r, 76 7[thin space (1/6-em)]:[thin space (1/6-em)]1
18 4-ClC6H4 H 2,4,6-Triisopropylphenyl Me tBu 3s, 83 4[thin space (1/6-em)]:[thin space (1/6-em)]1
19 4-BrC6H4 H 2,4,6-Triisopropylphenyl Me tBu 3t, 82 4[thin space (1/6-em)]:[thin space (1/6-em)]1
20 C6H5 H 4-Methylphenyl Me Et 3u, 85 5[thin space (1/6-em)]:[thin space (1/6-em)]1



image file: c5ra09147k-f2.tif
Fig. 2 X-ray crystal structure of the major diastereomeric product 3u.

Next, we examined the asymmetric [4 + 1] annulation of 1a with MBH carbonate 2a using natural amino acid derived chiral phosphine catalyst CP,18,19 giving the corresponding cycloadduct 3a in 78% isolated yield along with 7[thin space (1/6-em)]:[thin space (1/6-em)]1 dr and 61% ee value for the major diastereomeric isomer in toluene at room temperature (Scheme 2).


image file: c5ra09147k-s2.tif
Scheme 2 Asymmetric [4 + 1] annulation catalyzed by chiral phosphine catalyst CP.

On the basis of above experimental results and closely related reports,6d,8,9,10,11 a plausible reaction mechanism has been outlined in Scheme 3. PPh2Me attacks from the β-position of MBH carbonate 2 to take off carbon dioxide and t-BuOH, affording phosphorus ylide I, which undergoes the nucleophilic attack with α,β-unsaturated imine 1a to give the corresponding intermediate II. Subsequent hydrogen transfer produces intermediate III, which is followed by a Michael addition and elimination of PPh2Me to produce 3.


image file: c5ra09147k-s3.tif
Scheme 3 A plausible reaction mechanism.

In summary, we have developed an interesting phosphine-catalyzed regio- and diastereoselective [4 + 1] annulation of MBH carbonates with oxindole-derived α,β-unsaturated imines, affording the corresponding functionalized 1′,2′-(dihydrospiro[indoline-3,3′-pyrrol]-2′-yl)acrylates in moderate to good yields and dr values under mild conditions. A plausible reaction mechanism has also been proposed on the basis of previous literature. Further efforts in our laboratory will focus on exploring the more effective asymmetric version and possible application of this annulation in organic synthesis.

Acknowledgements

We are grateful for the financial support from the National Basic Research Program of China (973)-2015CB856603, and the National Natural Science Foundation of China (20472096, 21372241, 21361140350, 20672127, 21421091, 21372250, 21121062, 21302203 and 20732008).

Notes and references

  1. For selected reviews, see: (a) C. Marti and E. M. Carreia, Eur. J. Org. Chem., 2003, 2209 CrossRef CAS PubMed; (b) C. V. Galliford and K. A. Scheidt, Angew. Chem., Int. Ed., 2007, 46, 8748 CrossRef CAS PubMed; (c) G. S. Singh and Z. Y. Desta, Chem. Rev., 2012, 112, 6104 CrossRef CAS PubMedFor selected papers, see: (d) P. R. Sebahar and R. M. Williams, J. Am. Chem. Soc., 2000, 122, 5666 CrossRef CAS; (e) A. H. Abdel-Rahman, E. M. Keshk, M. A. Hanna and Sh. M. EI-Bady, Bioorg. Med. Chem., 2004, 12, 2483 CrossRef CAS PubMed; (f) T.-L. Liu, Z.-Y. Xue, H.-Y. Tao and C.-J. Wang, Org. Biomol. Chem., 2011, 9, 1980 RSC; (g) T.-L. Liu, Z.-L. He, Q.-H. Li, H.-Y. Tao and C.-J. Wang, Adv. Synth. Catal., 2011, 353, 1713 CrossRef CAS PubMed; (h) Y. Cao, X. Jiang, L. Liu, F. Shen, F. Zhang and R. Wang, Angew. Chem., Int. Ed., 2011, 50, 9124 CrossRef CAS PubMed; (i) A. Awata and T. Arai, Chem.–Eur. J., 2012, 18, 8278 CrossRef CAS PubMed.
  2. (a) M. M.-C. Lo, C. S. Newmann, S. Nagayams, E. O. Perlstein and S. L. Schreiber, J. Am. Chem. Soc., 2005, 127, 10130 CrossRef PubMed; (b) V. V. Vintonyak, K. Warburg, H. Kruse, S. Grimme, K. Hubel, D. Rauth and H. Waldmann, Angew. Chem., Int. Ed., 2010, 49, 5902 CrossRef CAS PubMed; (c) G. K. Nutan, M. Modi, S. K. Gupta and R. K. Singh, Eur. J. Med. Chem., 2011, 46, 1181 CrossRef PubMed.
  3. For selected reviews, see: (a) A. B. Dounay and L. E. Overman, Chem. Rev., 2003, 103, 2945 CrossRef CAS PubMed; (b) B. M. Trost and M. K. Brennan, Synthesis, 2009, 3003 CrossRef CAS; (c) F. Zhou, Y. Liu and J. Zhou, Adv. Synth. Catal., 2010, 352, 1381 CrossRef CAS PubMedFor selected papers, see: (d) B. M. Trost, N. Cramer and S. M. Silverman, J. Am. Chem. Soc., 2007, 129, 12396 CrossRef CAS PubMed; (e) X. Chen, Q. Wei, S. Luo, H. Xiao and L.-Z. Gong, J. Am. Chem. Soc., 2009, 131, 13819 CrossRef CAS PubMed; (f) Q. Wei and L.-Z. Gong, Org. Lett., 2010, 12, 1008 CrossRef CAS PubMed.
  4. For selected reviews, see: (a) X. Lu, C. Zhang and Z. Xu, Acc. Chem. Res., 2001, 34, 535 CrossRef CAS PubMed; (b) J. L. Methot and W. R. Roush, Adv. Synth. Catal., 2004, 346, 1035 CrossRef CAS PubMed; (c) L.-W. Ye, J. Zhou and Y. Tang, Chem. Soc. Rev., 2008, 37, 1140 RSC; (d) B. J. Cowen and S. J. Miller, Chem. Soc. Rev., 2009, 38, 3102 RSC; (e) A. Marinetti and A. Voituriez, Synlett, 2010, 174 CrossRef CAS PubMed; (f) Z.-M. Wang, X.-Z. Xu and O. Kwon, Chem. Soc. Rev., 2014, 43, 2927 RSC.
  5. For selected reviews, see: (a) S. E. Denmark and G. L. Beutner, Angew. Chem., Int. Ed., 2008, 47, 1560 CrossRef CAS PubMed; (b) A. Marinetti and A. Voituriez, Synlett, 2010, 174 CrossRef CAS PubMed; (c) S. Xu and Z. He, Sci. Sin.: Chim., 2010, 40, 856 Search PubMed.
  6. (a) Y. Du, X. Lu and C. Zhang, Angew. Chem., Int. Ed., 2003, 42, 1035 CrossRef CAS PubMed; (b) Y. Du, J. Feng and X. Lu, Org. Lett., 2005, 7, 1987 CrossRef CAS PubMed; (c) J. Feng, X. Lu, A. Kong and X. Han, Tetrahedron, 2007, 63, 6035 CrossRef CAS PubMed; (d) S. Zheng and X. Lu, Org. Lett., 2008, 10, 4481 CrossRef CAS PubMed; (e) S. Zheng and X. Lu, Tetrahedron Lett., 2009, 50, 4532 CrossRef CAS PubMed; (f) S. Zheng and X. Lu, Org. Lett., 2009, 11, 3978 CrossRef CAS PubMed.
  7. (a) C.-W. Cho, J.-R. Kong and M. J. Krische, Org. Lett., 2004, 6, 1337 CrossRef CAS PubMed; (b) C.-W. Cho and M. J. Krische, Angew. Chem., Int. Ed., 2004, 43, 6689 CrossRef CAS PubMed; (c) B. M. Trost, R. M. Machacek and H. C. Tsui, J. Am. Chem. Soc., 2005, 127, 7014 CrossRef CAS PubMed; (d) Y.-S. Du, X.-L. Han and X.-Y. Lu, Tetrahedron Lett., 2004, 45, 4967 CrossRef CAS PubMed; (e) D. J. V. C. van Steenis, T. Marcelli, M. Lutz, A. L. Spek, J. H. van Maarseveen and H. Hiemstra, Adv. Synth. Catal., 2007, 349, 281 CrossRef CAS PubMed; (f) Y.-Q. Jiang, Y.-L. Shi and M. Shi, J. Am. Chem. Soc., 2008, 130, 7202 CrossRef CAS PubMed; (g) H.-L. Cui, X. Feng, J. Peng, J. Lei, K. Jiang and Y.-C. Chen, Angew. Chem., Int. Ed., 2009, 48, 5737 CrossRef CAS PubMed; (h) J. Peng, X. Huang, H.-L. Cui and Y.-C. Chen, Org. Lett., 2010, 12, 4260 CrossRef CAS PubMed; (i) T. Furukawa, T. Nishimine, E. Tokunaga, K. Hasegawa, M. Shiro and N. Shibata, Org. Lett., 2011, 13, 3972 CrossRef CAS PubMed; (j) T. Furukawa, J. Kawazoe, W. Zhang, T. Nishimine, E. Tokunaga, T. Matsumoto, M. Shiro and N. Shibata, Angew. Chem., Int. Ed., 2011, 50, 9684 CrossRef CAS PubMed; (k) F. Zhong, J. Luo, G. Y. Chen, X. Dou and Y. Lu, J. Am. Chem. Soc., 2012, 134, 10222 CrossRef CAS PubMed; (l) G.-Y. Chen, F. Zhong and Y. Lu, Org. Lett., 2012, 14, 3955 CrossRef CAS PubMed; (m) B. Wang, X. Companyó, J. Li, A. Moyano and R. Rios, Tetrahedron Lett., 2012, 53, 4124 CrossRef CAS PubMed; (n) R. Zhou, J.-F. Wang, H.-B. Song and Z.-J. He, Org. Lett., 2011, 13, 580 CrossRef CAS PubMed; (o) M. Yang, T. Wang, S. Cao and Z. He, Chem. Commun., 2014, 50, 13506 RSC.
  8. Z.-L. Chen and J.-L. Zhang, Chem.–Asian J., 2010, 5, 1542 CrossRef CAS PubMed.
  9. (a) P.-Z. Xie, Y. Huang and R.-Y. Chen, Org. Lett., 2010, 12, 3768 CrossRef CAS PubMed; (b) P.-Z. Xie, E.-Q. Li, J. Zheng, X. Li, Y. Huang and R.-Y. Chen, Adv. Synth. Catal., 2013, 355, 161 CrossRef CAS PubMed.
  10. (a) J.-J. Tian, R. Zhou, H.-B. Song and Z.-J. He, J. Org. Chem., 2011, 76, 2374 CrossRef CAS PubMed; (b) R. Zhou, C. Duan, C.-J. Yang and Z.-J. He, Chem.–Asian J., 2014, 9, 1183 CrossRef CAS PubMed.
  11. (a) X.-N. Zhang, H.-P. Deng, L. Huang, Y. Wei and M. Shi, Chem. Commun., 2012, 48, 8664 RSC; (b) F.-L. Hu, Y. Wei and M. Shi, Chem. Commun., 2014, 50, 8912 RSC; (c) Y. Wei and M. Shi, Chem. Rev., 2013, 113, 6659 CrossRef CAS PubMed; (d) Y. Wei and M. Shi, Chem.–Asian J., 2014, 9, 2720 CrossRef CAS PubMed.
  12. X.-Y. Han, W.-J. Yao, T.-L. Wang, Y.-R. Tan, Z.-Y. Yan, J. Kwiatkowski and Y.-X. Lu, Angew. Chem., Int. Ed., 2014, 53, 5643 CrossRef CAS PubMed.
  13. S. Kramer and G. C. Fu, J. Am. Chem. Soc., 2015, 137, 3803 CrossRef CAS PubMed.
  14. (a) X.-N. Zhang, G.-Q. Chen, X.-Y. Tang, Y. Wei and M. Shi, Angew. Chem., Int. Ed., 2014, 53, 10768 CrossRef CAS PubMed; (b) M. Yang, T.-Y. Wang, S.-X. Cao and Z.-J. He, Chem. Commun., 2014, 50, 13506 RSC.
  15. Q.-M. Zhang, L. Yang and X.-F. Tong, J. Am. Chem. Soc., 2010, 132, 2551 Search PubMed.
  16. (a) B. Han, J.-L. Li, C. Ma, S.-J. Zhang and Y.-C. Chen, Angew. Chem., Int. Ed., 2008, 47, 9971 CrossRef CAS PubMed; (b) B. Han, Z.-Q. He, J.-L. Li, R. Li, K. Jiang, T.-Y. Liu and Y.-C. Chen, Angew. Chem., Int. Ed., 2009, 48, 5474 CrossRef CAS PubMed; (c) Z.-G. Shi, Q.-J. Tong, W. W. Y. Leong and G.-F. Zhong, Chem.–Eur. J., 2012, 18, 9802 CrossRef CAS PubMed; (d) Z. Shi, P. Yu, T.-P. Loh and G. Zhong, Angew. Chem., Int. Ed., 2012, 51, 7825 CrossRef CAS PubMed; (e) L. Hao, S.-J. Chen, J.-F. Xu, B. Tiwari, Z.-Q. Fu, T. Li, J.-Y. Lim and Y. R. Chi, Org. Lett., 2013, 15, 4956 CrossRef CAS PubMed; (f) D.-D. Tang, Y. Wang, J.-R. Wang and P.-F. Xu, Tetrahedron Lett., 2014, 55, 4133 CrossRef CAS PubMed; (g) E.-Q. Li, P.-H. Jia, L. Liang and Y. Huang, ACS Catal., 2014, 4, 600 CrossRef CAS; (h) D. G. Stark, T. J. C. O'Riordan and A. D. Smith, Org. Lett., 2014, 16, 6496 CrossRef CAS PubMed.
  17. For N-heterocyclic carbene-catalyzed reactions of oxindole-derived α,β-unsaturated imines to construct spirocyclic oxindoles, see: (a) K. J. B. Tiwari and Y. R. Chi, Org. Lett., 2012, 14, 2382 CrossRef PubMed; (b) L. Hao, C.-W. Chuen, R. Ganguly and Y. R. Chi, Synlett, 2013, 24, 1197 CrossRef CAS PubMedFor phosphine-catalyzed asymmetric [4 + 2] annulation with oxindole-derived α,β-unsaturated imines, see: (c) X. N. Zhang, G.-Q. Chen, X. Dong, Y. Wei and M. Shi, Adv. Synth. Catal., 2013, 355, 3351 CrossRef CAS PubMed.
  18. The CIF data of major diastereoisomers of 3t and 3u have been deposited in CCDC with numbers 1024783 and 1019412..
  19. S.-X. Wang, X.-Y. Han, F.-G. Zhong, Y.-Q. Wang and Y.-X. Lu, Synlett, 2011, 19, 2766 Search PubMed.

Footnote

Electronic supplementary information (ESI) available: Experimental procedures, characterization data of new compounds. CCDC 1024783 and 1019412. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5ra09147k

This journal is © The Royal Society of Chemistry 2015
Click here to see how this site uses Cookies. View our privacy policy here.